Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$573,750.00
Apr 1, 2017
Function of circular RNA in prostate cancer development and progression
$669,375.00
Apr 1, 2017
HB-EGF as a central regulator of pancreatic beta-cell proliferation.
$1,101,600.00
Apr 1, 2017
Novel Aspects of the regulation of intestinal lipoprotein particle secretion in humans
$634,950.00
Apr 1, 2017
Role and therapeutic potential of RGS16 in pancreatic beta cells.
$742,050.00
Apr 1, 2017
Inhibition of Netrin-1 Dependence Receptor Binding as a Targeted Approach for Cancer Therapy
$1,082,476.00
Apr 1, 2017
Protein and Exercise to Reverse Frailty in OldeR Men and women undergoing TAVR: The PERFORM-TAVR Trial
$860,625.00
Apr 1, 2017
Optimizing Combination Strategies for GPNMB-expressing Triple Negative Breast Cancers
$902,700.00
Apr 1, 2017
A new Argonaute-2 binding protein with key roles in neural crest cells
$100,000.00
Apr 1, 2017
Impacts of novel HCV and addiction treatment modalities on engagement in the HCV cascade of care among people who inject drugs
$100,000.00
Apr 1, 2017
Understanding and subverting bacterial immune avoidance